Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Mol Cell Proteomics ; 15(3): 866-77, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-26463340

RESUMEN

Histone post-translational modifications (hPTMs) generate a complex combinatorial code that has been implicated with various pathologies, including cancer. Dissecting such a code in physiological and diseased states may be exploited for epigenetic biomarker discovery, but hPTM analysis in clinical samples has been hindered by technical limitations. Here, we developed a method (PAThology tissue analysis of Histones by Mass Spectrometry - PAT-H-MS) that allows to perform a comprehensive, unbiased and quantitative MS-analysis of hPTM patterns on formalin-fixed paraffin-embedded (FFPE) samples. In pairwise comparisons, histone extracted from formalin-fixed paraffin-embedded tissues showed patterns similar to fresh frozen samples for 24 differentially modified peptides from histone H3. In addition, when coupled with a histone-focused version of the super-SILAC approach, this method allows the accurate quantification of modification changes among breast cancer patient samples. As an initial application of the PAThology tissue analysis of Histones by Mass Spectrometry method, we analyzed breast cancer samples, revealing significant changes in histone H3 methylation patterns among Luminal A-like and Triple Negative disease subtypes. These results pave the way for retrospective epigenetic studies that combine the power of MS-based hPTM analysis with the extensive clinical information associated with formalin-fixed paraffin-embedded archives.


Asunto(s)
Neoplasias de la Mama/patología , Carcinoma Ductal de Mama/patología , Histonas/metabolismo , Leucemia Promielocítica Aguda/patología , Procesamiento Proteico-Postraduccional , Espectrometría de Masas en Tándem/métodos , Animales , Neoplasias de la Mama/metabolismo , Carcinoma Ductal de Mama/metabolismo , Línea Celular Tumoral , Femenino , Humanos , Leucemia Promielocítica Aguda/metabolismo , Metilación , Ratones , Proteómica/métodos , Fijación del Tejido
2.
Hum Mol Genet ; 21(24): 5294-305, 2012 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-22983956

RESUMEN

Neurodegeneration with brain iron accumulation (NBIA) comprises a group of neurodegenerative disorders characterized by high brain content of iron and presence of axonal spheroids. Mutations in the PANK2 gene, which encodes pantothenate kinase 2, underlie an autosomal recessive inborn error of coenzyme A metabolism, called pantothenate kinase-associated neurodegeneration (PKAN). PKAN is characterized by dystonia, dysarthria, rigidity and pigmentary retinal degeneration. The pathogenesis of this disorder is poorly understood and, although PANK2 is a mitochondrial protein, perturbations in mitochondrial bioenergetics have not been reported. A knock-out (KO) mouse model of PKAN exhibits retinal degeneration and azoospermia, but lacks any neurological phenotype. The absence of a clinical phenotype has partially been explained by the different cellular localization of the human and murine PANK2 proteins. Here we demonstrate that the mouse Pank2 protein localizes to mitochondria, similar to its human orthologue. Moreover, we show that Pank2-defective neurons derived from KO mice have an altered mitochondrial membrane potential, a defect further corroborated by the observations of swollen mitochondria at the ultra-structural level and by the presence of defective respiration.


Asunto(s)
Sistema Nervioso Central/enzimología , Mitocondrias/metabolismo , Membranas Mitocondriales/metabolismo , Enfermedades Neurodegenerativas/enzimología , Estrés Oxidativo/fisiología , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Animales , Sistema Nervioso Central/metabolismo , Humanos , Potenciales de la Membrana/genética , Potenciales de la Membrana/fisiología , Ratones , Ratones Noqueados , Mitocondrias/genética , Enfermedades Neurodegenerativas/genética , Estrés Oxidativo/genética , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética
3.
J Biol Chem ; 287(31): 25782-94, 2012 Jul 27.
Artículo en Inglés | MEDLINE | ID: mdl-22669976

RESUMEN

Spinal muscular atrophy is a fatal genetic disease of motoneurons due to loss of full-length survival of motor neuron protein, the main product of the disease gene SMN1. Axonal SMN (a-SMN) is an alternatively spliced isoform of SMN1, generated by retention of intron 3. To study a-SMN function, we generated cellular clones for the expression of the protein in mouse motoneuron-like NSC34 cells. The model was instrumental in providing evidence that a-SMN decreases cell growth and plays an important role in the processes of axon growth and cellular motility. In our conditions, low levels of a-SMN expression were sufficient to trigger the observed biological effects, which were not modified by further increasing the amounts of the expressed protein. Differential transcriptome analysis led to the identification of novel a-SMN-regulated factors, i.e. the transcripts coding for the two chemokines, C-C motif ligands 2 and 7 (CCL2 and CCL7), as well as the neuronal and myotrophic factor, insulin-like growth factor-1 (IGF1). a-SMN-dependent induction of CCL2 and IGF1 mRNAs resulted in increased intracellular levels and secretion of the respective protein products. Induction of CCL2 contributes to the a-SMN effects, mediating part of the action on axon growth and random cell motility, as indicated by chemokine knockdown and re-addition studies. Our results shed new light on a-SMN function and the underlying molecular mechanisms. The data provide a rational framework to understand the role of a-SMN deficiency in the etiopathogenesis of spinal muscular atrophy.


Asunto(s)
Axones/fisiología , Movimiento Celular , Quimiocina CCL2/metabolismo , Factor I del Crecimiento Similar a la Insulina/metabolismo , Neuronas/fisiología , Proteína 1 para la Supervivencia de la Neurona Motora/metabolismo , Axones/metabolismo , Línea Celular , Proliferación Celular , Forma de la Célula , Quimiocina CCL2/genética , Quimiocina CCL7/genética , Quimiocina CCL7/metabolismo , Perfilación de la Expresión Génica , Regulación de la Expresión Génica , Humanos , Factor I del Crecimiento Similar a la Insulina/genética , Neuronas/metabolismo , Transporte de Proteínas , Proteína 1 para la Supervivencia de la Neurona Motora/genética , Proteína 1 para la Supervivencia de la Neurona Motora/fisiología , Transcripción Genética , Transcriptoma
4.
Acta Neuropathol ; 124(6): 809-21, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23143229

RESUMEN

Aß is the main component of amyloid deposits in Alzheimer disease (AD) and its aggregation into oligomers, protofibrils and fibrils is considered a seminal event in the pathogenesis of AD. Aß with C-terminus at residue 42 is the most abundant species in parenchymal deposits, whereas Aß with C-terminus at residue 40 predominates in the amyloid of the walls of large vessels. Aß peptides with other C-termini have not yet been thoroughly investigated. We analysed Aß38 in the brains of patients with Aß deposition linked to sporadic and familial AD, hereditary cerebral haemorrhage with amyloidosis, or Down syndrome. Immunohistochemistry, confocal microscopy, immunoelectron microscopy, immunoprecipitation and the electrophoresis separation of low molecular weight aggregates revealed that Aß38 accumulates consistently in the brains of patients carrying APP mutations in the Aß coding region, but was not detected in the patients with APP mutations outside the Aß domain, in the patients with presenilin mutations or in subjects with Down syndrome. In the patients with sporadic AD, Aß38 was absent in the senile plaques, but it was detected only in the vessel walls of a small subset of patients with severe cerebral amyloid angiopathy. Our results suggest that APP mutations in the Aß coding region favour Aß38 accumulation in the brain and that the molecular mechanisms of Aß deposition in these patients may be different from those active in patients with familial AD associated with other genetic defects and sporadic AD.


Asunto(s)
Enfermedad de Alzheimer/patología , Péptidos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Angiopatía Amiloide Cerebral/patología , Mutación/genética , Fragmentos de Péptidos/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Precursor de Proteína beta-Amiloide/metabolismo , Encéfalo/metabolismo , Encéfalo/patología , Angiopatía Amiloide Cerebral/genética , Angiopatía Amiloide Cerebral/metabolismo , Humanos , Persona de Mediana Edad , Sistemas de Lectura Abierta
5.
J Struct Biol ; 171(1): 11-7, 2010 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-20382230

RESUMEN

Bdelloid rotifers are aquatic microinvertebrates able to cope with the loss of environmental water by entering dormancy, and are thus capable of living in temporary habitats. When water is evaporating, bdelloids contract into "tuns", silence metabolism and lose water from the body, a condition known as anhydrobiosis. Under controlled conditions, a bdelloid species (Macrotrachela quadricornifera) was made anhydrobiotic, and its morphology was studied by light, confocal and electron microscopy. A compact anatomy characterizes the anhydrobiotic rotifer, resulting in a considerable reduction of its body volume: the internal organs, precisely packed together, occupy the body cavity almost completely and the lumen of hollow organs disappears. Remarkable ultrastructural changes characterize the anhydrobiotic condition. The mitochondria are wholly surrounded by a ring of electron-dense particles, and the epidermal pores, open in the hydrated specimens, become gradually closed by structures similar to epithelial junctions. The cilia are densely packed: microtubules are still identifiable, but the axonemal organization appears disrupted. This is the first extensive comparative study on the morphological changes associated with the anhydrobiosis process in a rotifer, providing the basis for an improved understanding of the processes involved in this extreme adaptation.


Asunto(s)
Rotíferos/anatomía & histología , Aclimatación , Animales , Tamaño Corporal , Desecación , Microscopía Electrónica de Rastreo , Microscopía Electrónica de Transmisión , Rotíferos/fisiología , Rotíferos/ultraestructura , Agua
6.
Acta Neuropathol ; 120(6): 803-12, 2010 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20842367

RESUMEN

Mutations of three different genes, encoding ß-amyloid precursor protein (APP), presenilin 1 and presenilin 2 are associated with familial Alzheimer's disease (AD). Recently, the APP mutation A673V has been identified that stands out from all the genetic defects previously reported in these three genes, since it causes the disease only in the homozygous state (Di Fede et al. in Science 323:1473-1477, 2009). We here provide the detailed neuropathological picture of the proband of this family, who was homozygous for the APP A673V mutation and recently came to death. The brain has been studied by histological and immunohistochemical techniques, at the optical and ultrastructural levels. Cerebral Aß accumulation and tau pathology were severe and extensive. Peculiar features were the configuration of the Aß deposits that were of large size, mostly perivascular and exhibited a close correspondence between the pattern elicited by amyloid stainings and the labeling obtained with immunoreagents specific for Aß40 or Aß42. Moreover, Aß deposition spared the neostriatum while deeply affecting the cerebellum, and therefore was not in compliance with the hierarchical topographical sequence of involvement documented in sporadic AD. Therefore, the neuropathological picture of familial AD caused by the APP recessive mutation A673V presents distinctive characteristics compared to sporadic AD or familial AD inherited as a dominant trait. Main peculiar features are the morphology, structural properties and composition of the Aß deposits as well as their topographic distribution in the brain.


Asunto(s)
Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/patología , Sustitución de Aminoácidos/genética , Péptidos beta-Amiloides/genética , Péptidos beta-Amiloides/metabolismo , Precursor de Proteína beta-Amiloide/genética , Genes Recesivos/genética , Alanina/genética , Enfermedad de Alzheimer/metabolismo , Péptidos beta-Amiloides/ultraestructura , Precursor de Proteína beta-Amiloide/ultraestructura , Predisposición Genética a la Enfermedad/genética , Humanos , Masculino , Persona de Mediana Edad , Valina/genética
7.
Nat Commun ; 10(1): 2115, 2019 05 09.
Artículo en Inglés | MEDLINE | ID: mdl-31073170

RESUMEN

Approximately 30% of ERα breast cancer patients relapse with metastatic disease following adjuvant endocrine therapies. The connection between acquisition of drug resistance and invasive potential is poorly understood. In this study, we demonstrate that the type II keratin topological associating domain undergoes epigenetic reprogramming in aromatase inhibitors (AI)-resistant cells, leading to Keratin-80 (KRT80) upregulation. KRT80 expression is driven by de novo enhancer activation by sterol regulatory element-binding protein 1 (SREBP1). KRT80 upregulation directly promotes cytoskeletal rearrangements at the leading edge, increased focal adhesion and cellular stiffening, collectively promoting cancer cell invasion. Shearwave elasticity imaging performed on prospectively recruited patients confirms KRT80 levels correlate with stiffer tumors. Immunohistochemistry showed increased KRT80-positive cells at relapse and, using several clinical endpoints, KRT80 expression associates with poor survival. Collectively, our data uncover an unpredicted and potentially targetable direct link between epigenetic and cytoskeletal reprogramming promoting cell invasion in response to chronic AI treatment.


Asunto(s)
Antineoplásicos Hormonales/farmacología , Neoplasias de la Mama/patología , Citoesqueleto/patología , Queratinas Tipo II/genética , Recurrencia Local de Neoplasia/patología , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/metabolismo , Antineoplásicos Hormonales/uso terapéutico , Inhibidores de la Aromatasa/farmacología , Inhibidores de la Aromatasa/uso terapéutico , Mama/patología , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/genética , Neoplasias de la Mama/mortalidad , Movimiento Celular/efectos de los fármacos , Movimiento Celular/genética , Citoesqueleto/genética , Resistencia a Antineoplásicos/genética , Elementos de Facilitación Genéticos/genética , Epigénesis Genética , Receptor alfa de Estrógeno/metabolismo , Femenino , Regulación Neoplásica de la Expresión Génica , Humanos , Queratinas Tipo II/metabolismo , Células MCF-7 , Invasividad Neoplásica/genética , Invasividad Neoplásica/patología , Recurrencia Local de Neoplasia/tratamiento farmacológico , Recurrencia Local de Neoplasia/genética , Recurrencia Local de Neoplasia/mortalidad , Pronóstico , Dominios Proteicos/genética , Regulación hacia Arriba
9.
J Morphol ; 273(1): 1-7, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22161998

RESUMEN

Bdelloid rotifers survive desiccation and starvation by halting activity and entering a kind of dormancy. To understand the mechanisms of survival in the absence of food source, we studied the anatomical and ultrastructural changes occurring in a bdelloid species, Macrotrachela quadricornifera Milne 1886, after starvation for different periods. The starved rotifers present a progressive reduction of body size accompanied with a consistent reduction of the volume of the stomach syncytium, where lipid inclusions and digestive vacuoles tend to fade with prolonged starvation. Similar reduction occurs in the vitellarium gland, in which yolk granules progressively decrease in number and size. The changes observed in the syncytia of the stomach and the vitellarium suggest that during starvation M. quadricornifera uses resources diverted from the stomach syncytium first and from the vitellarium syncytium later, resources that are normally allocated to reproduction. The fine structure of starved bdelloids is compared with that of anhydrobiotic bdelloids, revealing that survival during either forms of dormancy is sustained by different physiological mechanisms.


Asunto(s)
Rotíferos/fisiología , Rotíferos/ultraestructura , Inanición , Adaptación Fisiológica , Animales , Desecación , Reproducción
10.
Neurobiol Aging ; 33(4): 834.e1-6, 2012 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21943955

RESUMEN

Frontotemporal lobar degeneration (FTLD) can be sporadic or familial. The genes encoding the microtubule-associated protein tau (MAPT) and progranulin (GRN) are the most relevant genes so far known causing the hereditary forms. Following genetic screening of patients affected by FTLD, we identified 2 new MAPT mutations, P364S and G366R, the former in a sporadic case. In the study we report the clinical and genetic features of the patients carrying these mutations, and the functional effects of the mutations, analyzed in vitro in order to investigate their pathogenic character. Both mutations resulted in reduced ability of tau to promote microtubule polymerization; the P364S protein variant also showed a high propensity to aggregate into filaments. These results suggest a high probability that these mutations are pathogenic. Our findings highlight the importance of genetic analysis also in sporadic forms of FTLD, and the role of in vitro studies to evaluate the pathologic features of new mutations.


Asunto(s)
Degeneración Lobar Frontotemporal/genética , Degeneración Lobar Frontotemporal/patología , Mutación/genética , Proteínas tau/genética , Anciano , Análisis Mutacional de ADN , Exones/genética , Salud de la Familia , Femenino , Humanos , Italia , Imagen por Resonancia Magnética , Masculino , Microtúbulos/metabolismo , Microtúbulos/patología , Persona de Mediana Edad , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Proteínas tau/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA